mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.002 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.002 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.002 |